Is Monday.com (MNDY) a Buy as Wall Street Analysts Look Optimistic?

Monday.com (MNDY) currently boasts an Average Brokerage Recommendation (ABR) of 1.32, signifying a strong buy consensus from 25 firms with 80% 'Strong Buy' ratings. However, this optimism is sharply contrasted by a 30.1% decline in the Zacks Consensus Estimate for MNDY's current year earnings over the past month, pushing it to $3.93 and resulting in a Zacks Rank #5 (Strong Sell). This divergence suggests that despite Wall Street's positive ABR, the company's deteriorating earnings outlook, a more reliable indicator, points to potential near-term price weakness for MNDY, cautioning investors against relying solely on brokerage recommendations.

Analysis

A significant divergence exists between Wall Street's sentiment and fundamental earnings momentum for Monday.com (MNDY), presenting a notable risk for investors. While the stock carries a bullish Average Brokerage Recommendation (ABR) of 1.32, with 88% of the 25 covering firms rating it a Buy or Strong Buy, this optimism is sharply contradicted by deteriorating earnings prospects. The Zacks Consensus Estimate for the current year's earnings per share has plummeted 30.1% over the past month to $3.93. This strong agreement among analysts in revising EPS estimates lower has triggered a Zacks Rank #5 (Strong Sell), which is historically correlated with near-term stock price underperformance. The core conflict suggests that the lagging indicator of static analyst ratings may be masking a more timely and powerful negative signal from the trend in earnings estimate revisions, flagging potential for a near-term stock price decline.

Key Decisions for Investors

• Investors should view the highly positive sell-side analyst consensus with significant caution, as it is directly challenged by a severe and recent downturn in the company's earnings forecast.
• The 30.1% decline in the current-year consensus EPS estimate and the resulting Zacks Rank #5 (Strong Sell) represent a material red flag for potential near-term price weakness.
• It is prudent to prioritize monitoring trends in earnings estimate revisions over headline brokerage ratings, as these revisions are presented as a more reliable leading indicator for MNDY's stock performance.